Evotec SE (FRA:EVT)
Germany · Delayed Price · Currency is EUR 6.32
+0.00 (0.06%)
At close: Jan 9, 2026
Evotec SE Employees
Evotec SE had 4,740 employees as of December 31, 2024. The number of employees decreased by 321 or -6.34% compared to the previous year.
Employees
4,740
Change (1Y)
-321
Growth (1Y)
-6.34%
Revenue / Employee
€157,963
Profits / Employee
€33,204
Market Cap
1.11B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4,740 | -321 | -6.34% |
| Dec 31, 2023 | 5,061 | 109 | 2.20% |
| Dec 31, 2022 | 4,952 | 754 | 17.96% |
| Dec 31, 2021 | 4,198 | 626 | 17.53% |
| Dec 31, 2020 | 3,572 | 542 | 17.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 317,562 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 98,995 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Evotec SE News
- 3 days ago - Evotec SE (EVO) Secures Gates Foundation Grant for Biotherapeutics - GuruFocus
- 3 days ago - Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access - Accesswire
- 3 days ago - Evotec Secures Grant to Use AI for Cost-Effective Monoclonal Antibody Development - Wallstreet:Online
- 3 days ago - EQS-News: Just – Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access - Wallstreet:Online
- 9 days ago - Evotec SE: Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations - Finanz Nachrichten
- 9 days ago - Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations - Accesswire
- 10 days ago - Evotec Names Dr. Sarah Fakih as New EVP of Global Communications & IR - Wallstreet:Online
- 10 days ago - EQS-News: Evotec appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations - Wallstreet:Online